Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report)’s stock price rose 21.2% during trading on Thursday . The company traded as high as C$0.21 and last traded at C$0.20. Approximately 292,294 shares traded hands during mid-day trading, a decline of 46% from the average daily volume of 538,273 shares. The stock had previously closed at C$0.17.
Voyageur Pharmaceuticals Stock Down 10.0 %
The company has a debt-to-equity ratio of 3.21, a current ratio of 0.17 and a quick ratio of 0.84. The company has a market capitalization of C$25.10 million, a PE ratio of -18.00 and a beta of 0.32. The company has a 50-day moving average of C$0.11 and a two-hundred day moving average of C$0.08.
Voyageur Pharmaceuticals Company Profile
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.
Further Reading
- Five stocks we like better than Voyageur Pharmaceuticals
- High Dividend REITs: Are They an Ideal Way to Diversify?
- ServiceNow Stock Slips, But AI Expansion Signals Long-Term Gains
- 5 discounted opportunities for dividend growth investors
- Microsoft and Meta’s AI Investment Plans Are Full Steam Ahead
- Bank Stocks – Best Bank Stocks to Invest In
- Beyond Self-Driving Cars: Factory Automation Takes Center Stage
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
